We are live on ! Find out more
GCTK icon

GlucoTrack

8 hedge funds and large institutions have $41.5K invested in GlucoTrack in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $40.1K → $41.5K (+$1.42K)

0.68% more ownership

Funds ownership: 0.02%0.7% (+0.68%)

20% less funds holding

Funds holding: 108 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
8
Holders Change
-2
Holders Change %
-20%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

GCTK Hedge Fund Activity: Q3 2025 in Review

8 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q3 2025, worth a combined $41.5K — up 3.5% from $40.1K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of GCTK and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Alerus Financial, opening a new position worth an estimated $30.1K. The largest seller was Bank of America, cutting an estimated $24.6K.

  • 8 institutional investors held GlucoTrack (GCTK) as of Q3 2025, down from 10 in Q2 2025.
  • Funds reported $41.5K of GlucoTrack stock for Q3 2025, up 3.5% quarter-over-quarter.
  • 1 fund opened new GlucoTrack positions in Q3 2025 and 3 closed out, a net change of -2 holders.
  • The largest GlucoTrack buyer in Q3 2025 was Alerus Financial, an estimated $30.1K added.
  • The largest GlucoTrack seller in Q3 2025 was Bank of America, an estimated $24.6K sold.

Based on aggregated 13F filings for Q3 2025.